Medical management of overactive bladder
| Autor: | Sarvpreet S Ubee, Ramaswamy Manikandan, Gurpreet Singh |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2010 |
| Předmět: | |
| Zdroj: | Indian Journal of Urology, Vol 26, Iss 2, Pp 270-278 (2010) |
| Druh dokumentu: | article |
| ISSN: | 0970-1591 1998-3824 |
| DOI: | 10.4103/0970-1591.65403 |
| Popis: | Overactive bladder (OAB), as defined by the International Continence Society, is characterized by a symptom complex including urinary urgency with or without urge incontinence, usually associated with frequency and nocturia. OAB syndrome has an incidence reported from six European countries ranging between 12-17%, while in the United States; a study conducted by the National Overactive Bladder Evaluation program found the incidence at 17%. In Asia, the prevalence of OAB is reported at 53.1%. In about 75%, OAB symptoms are due to idiopathic detrusor activity; neurological disease, bladder outflow obstruction (BOO) intrinsic bladder pathology and other chronic pelvic floor disorders are implicated in the others. OAB can be diagnosed easily and managed effectively with both non-pharmacological and pharmacological therapies. The first-line treatments are lifestyle interventions, bladder training, pelvic floor muscle exercises and anticholinergic drugs. Antimuscarinics are the drug class of choice for OAB symptoms; with proven efficacy, and adverse event profiles that differ somewhat. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|